Maxime Dely on a Hopeful Horizon: Promising Advances in Extending Platelet Power
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
“Platelets don’t sleep: The race to preserve their power longer
This is one of the most strategic questions in transfusion medicine today, as demand rises and logistical constraints tighten.
Platelets are unique cells: living, sensitive, and highly reactive. The moment they leave the human body, they begin a slow deterioration known as the “storage lesion”.
This process alters their metabolism, shape, and aggregation capacity — ultimately impacting their clinical effectiveness.
For a long time, this degradation was considered inevitable. But recent advances are changing the landscape.

Current research highlights several promising pathways:
• Platelet additive solutions (PAS) help reduce spontaneous activation and improve metabolic stability.
• Cold storage, once abandoned, is making a strong comeback thanks to its preservation of hemostatic function.
• Enhanced bag materials, pH control, and optimized agitation help limit the metabolic drift seen over time.
• Monitoring activation markers opens the door to finer, potentially dynamic quality control.
For hospital teams, the impact could be significant: less waste, more flexibility, and better matching between product and patient.
For patients, it means more effective and potentially safer transfusions.
When we look at a platelet concentrate today, we no longer just see a blood product — we see the result of years of research and the early signs of a new generation of transfusion solutions.
What if the next revolution simply came from a better way to preserve what saves lives every day?”
Advance your knowledge with Hemostasis Today.
-
Mar 9, 2026, 05:13Nicola Hancock: Shaping the Future of Stroke Care and the Stroke Action Plan for Europe at ELASF 2026
-
Mar 8, 2026, 16:19Simon Senanu: Crossmatch Procedures and Advanced Troubleshooting
-
Mar 8, 2026, 15:53Stuart Diamond: ApoB as a Key Marker of Cardiovascular Risk
-
Mar 8, 2026, 15:49Wolfgang Miesbach: Discussing Immunological Challenges in Hemophilia at GTH 2026
-
Mar 8, 2026, 15:41George Sands: AI Screening Tool for Early Detection of Heart Disease
-
Mar 8, 2026, 15:26Hussien Hishmat: The 2026 Guide to Pulmonary Embolism – Diagnosis Decoded
-
Mar 8, 2026, 15:01Raluca Simbotin: How We Care for Complex Patients Is A Measure of Healthcare System Maturity
-
Mar 8, 2026, 14:09Frederik Denorme։ PhD Position in Translational Stroke Research at the University of Antwerp
-
Mar 8, 2026, 14:03Akinchan Bhardwaj: Will Plaque Imaging Eventually Reshape Preventive Cardiology Workflows?